Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen Administration Guidelines for Persistent Ductus Arteriosus
NCT04282941Phase 3Unknown
- Sponsor
- Hospital La Paz Institute for Health Research
- Start
- Feb 2017
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ibuprofen in patent ductus arteriosus (PDA), sponsored by Hospital La Paz Institute for Health Research. Status: unknown.
02
Drugs
ibuprofen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on NCT04282941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04282941.